Genome wide screen identifies microsatellite markers associated with acute adverse effects following radiotherapy in cancer patients

BMC Medical Genetics

Volumn 11, Issue 1, 2010, Pages

  Michikawa, Yuichi ^a   Suga, Tomo ^a   Ishikawa, Atsuko ^a   Hayashi, Hideki ^b   Oka, Akira ^b   Inoko, Hidetoshi ^b   Iwakawa, Mayumi ^a   Imai, Takashi ^a  

^a NATIONAL INSTITUTE OF RADIOLOGICAL SCIENCES   (Japan)

^b TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

SEMAPHORIN 3A; SMALL INTERFERING RNA; MICROSATELLITE DNA;

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CONTROLLED STUDY; GENETIC ASSOCIATION; GENETIC SCREENING; GENETIC VARIABILITY; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MICROSATELLITE MARKER; PROMOTER REGION; RADIATION INJURY; RADIOSENSITIVITY; REPRODUCIBILITY; SKIN FIBROBLAST; TRANSCRIPTION INITIATION SITE; FIBROBLAST; GENETICS; NEOPLASM; RADIATION DOSE;

FIBROBLASTS; HUMANS; MICROSATELLITE REPEATS; NEOPLASMS; RADIATION TOLERANCE;

EID: 77955353563     PISSN: None     EISSN: 14712350     Source Type: Journal    
DOI: 10.1186/1471-2350-11-123     Document Type: Article

References (58)

1. Bentzen SM, Overgaard J. Patient-to-patient variability in the expression of radiation-induced normal tissue injury. Semin Radiat Oncol 1994, 4:68-80. 10.1016/S1053-4296(05)80034-7, 10717093.
2. Iwakawa M, Noda S, Yamada S, Yamamoto N, Miyazawa Y, Yamazaki H, Kawakami Y, Matsui Y, Tsujii H, Mizoe J, Oda E, Fukunaga Y, Imai T. Analysis of non-genetic risk factors for adverse skin reactions to radiotherapy among 284 breast cancer patients. Breast Cancer 2006, 13:300-307. 10.2325/jbcs.13.300, 16929125.
3. Andreassen CN, Alsner J, Overgaard J. Does variability in normal tissue reactions after radiotherapy have a genetic basis - where and how to look for it?. Radiother Oncol 2002, 64:131-140. 10.1016/S0167-8140(02)00154-8, 12242122.
4. Fernet M, Hall J. Genetic biomarkers of therapeutic radiation sensitivity. DNA Repair 2004, 3:1237-1243. 10.1016/j.dnarep.2004.03.019, 15279812.
5. Gatti RA. The inherited basis of human radiosensitivity. Acta Oncol 2001, 40:702-711. 10.1080/02841860152619115, 11765064.
6. Barnett GC, West CM, Dunning AM, Elliott RM, Coles CE, Pharoah PD, Burnet NG. Normal tissue reactions to radiotherapy: towards tailoring treatment dose by genotype. Nat Rev Cancer 2009, 9:134-142. 10.1038/nrc2587, 2670578, 19148183.
7. Andreassen CN, Alsner J. Genetic variants and normal tissue toxicity after radiotherapy: a systematic review. Radiother Oncol 2009, 92:299-309. 10.1016/j.radonc.2009.06.015, 19683821.
8. Iwakawa M, Noda S, Ohta T, Ohira C, Lee R, Goto M, Wakabayashi M, Matsui Y, Harada Y, Imai T. Different radiation susceptibility among five strains of mice detected by a skin reaction. J Radiat Res 2003, 44:7-13. 10.1269/jrr.44.7, 12841593.
9. Ohta T, Iwakawa M, Oohira C, Noda S, Minfu Y, Goto M, Tanaka H, Harada Y, Imai T. Fractionated irradiation augments inter-strain variation of skin reactions among three strains of mice. J Radiat Res 2004, 45:515-519. 10.1269/jrr.45.515, 15635260.
10. Iwakawa M, Noda S, Ohta T, Tanaka H, Tsuji A, Ishikawa A, Imai T. Strain dependent differences in a histological study of CD44 and collagen fibers with expression analysis of inflammatory response-related genes in irradiated murine lung. J Radiat Res 2004, 45:423-433. 10.1269/jrr.45.423, 15613788.
11. Noda S, Iwakawa M, Ohta T, Iwata M, Yang M, Goto M, Tanaka H, Harada Y, Imai T. Inter-strain variance in late phase of erythematous reaction or leg contracture after local irradiation among three strains of mice. Cancer Detect Prev 2005, 29:376-382. 10.1016/j.cdp.2005.06.005, 16164999.
12. Ishikawa K, Koyama-Saegusa K, Otsuka Y, Ishikawa A, Kawai S, Yasuda K, Suga T, Michikawa Y, Suzuki M, Iwakawa M, Imai T. Gene expression profile changes correlating with radioresistance in human cell lines. Int J Radiat Oncol Biol Phys 2006, 65:234-245.
13. Ban S, Ishikawa K, Kawai S, Koyama-Saegusa K, Ishikawa A, Shimada Y, Inazawa J, Imai T. Potential in a single cancer cell to produce heterogeneous morphology, radiosensitivity and gene expression. J Radiat Res 2005, 46:43-50. 10.1269/jrr.46.43, 15802858.
14. Tsuji AB, Sudo H, Sugyo A, Otsuki M, Miyagishi M, Taira K, Imai T, Harada YN. A fast, simple method for screening radiation susceptibility genes by RNA interference. Biochem Biophys Res Commun 2005, 333:1370-1377. 10.1016/j.bbrc.2005.06.047, 15979584.
15. Suga T, Ishikawa A, Kohda M, Otsuka Y, Yamada S, Yamamoto N, Shibamoto Y, Ogawa Y, Nomura K, Sho K, Omura M, Sekiguchi K, Kikuchi Y, Michikawa Y, Noda S, Sagara M, Ohashi J, Yoshinaga S, Mizoe J, Tsujii H, Iwakawa M, Imai T. Haplotype-based analysis of genes associated with risk of adverse skin reactions after radiotherapy in breast cancer patients. Int J Radiat Oncol Biol Phys 2007, 69:685-693.
16. Michikawa Y, Fujimoto K, Kinoshita K, Kawai S, Sugahara K, Suga T, Otsuka Y, Fujiwara K, Iwakawa M, Imai T. Reliable and fast allele-specific extension of 3'-LNA modified oligonucleotides covalently immobilized on a plastic base, combined with biotin-dUTP mediated optical detection. Anal Sci 2006, 22:1537-1545. 10.2116/analsci.22.1537, 17159312.
17. Michikawa Y, Suga T, Ohtsuka Y, Matsumoto I, Ishikawa A, Ishikawa K, Iwakawa M, Imai T. Visible genotype sensor array. Sensors 2008, 8:2722-2735.
18. Michikawa Y, Suga T, Ishikawa A, Ohtsuka Y, Iwakawa M, Imai T. Visible haplotype-tag SNP typing array device for human radiation sensitivity-associated genes. Oligonucleotide Array Sequence Analysis 2008, 3-14. New York: Nova Publishers, Moretti MK, Rizzo LJ.
19. Michikawa Y, Sugahara K, Suga T, Ohtsuka Y, Ishikawa K, Ishikawa A, Shiomi N, Shiomi T, Iwakawa M, Imai T. In-gel multiple displacement amplification of long DNA fragments diluted to the single molecule level. Anal Biochem 2008, 383:151-158. 10.1016/j.ab.2008.08.011, 18768135.
20. Payseur BA, Jing PA. Genomewide comparison of population structure at STRPs and nearby SNPs in humans. Mol Biol Evol 2009, 26:1369-1377. 10.1093/molbev/msp052, 2727377, 19289600.
21. Tamiya G, Shinya M, Imanishi T, Ikuta T, Makino S, Okamoto K, Furugaki K, Matsumoto T, Mano S, Ando S, Nozaki Y, Yukawa W, Nakashige R, Yamaguchi D, Ishibashi H, Yonekura M, Nakami Y, Takayama S, Endo T, Saruwatari T, Yagura M, Yoshikawa Y, Fujimoto K, Oka A, Chiku S, Linsen SE, Giphart MJ, Kulski JK, Fukazawa T, Hashimoto H, Kimura M, Hoshina Y, Suzuki Y, Hotta T, Mochida J, Minezaki T, Komai K, Shiozawa S, Taniguchi A, Yamanaka H, Kamatani N, Gojobori T, Bahram S, Inoko H. Whole genome association study of rheumatoid arthritis using 27039 microsatellites. Hum Mol Genet 2005, 14:2305-2321. 10.1093/hmg/ddi234, 16000323.
22. Kawashima M, Tamiya G, Oka A, Hohjoh H, Juji T, Ebisawa T, Honda Y, Inoko H, Tokunaga K. Genomewide Association Analysis of Human Narcolepsy and a New Resistance Gene. Am J Hum Genet 2006, 79:252-263. 10.1086/505539, 1559501, 16826516.
23. Meguro A, Ota M, Katsuyama Y, Oka A, Ohno S, Inoko H, Mizuki N. Association of the toll-like receptor 4 gene polymorphisms with Behçet's disease. Ann Rheum Dis 2008, 67:725-727. 10.1136/ard.2007.079871, 18408113.
24. Collins HE, Li H, Inda SE, Anderson J, Laiho K, Tuomilehto J, Seldin MF. A simple and accurate method for determination of microsatellite total allele content differences between DNA pools. Hum Genet 2000, 106:218-226. 10.1007/s004390051031, 10746564.
25. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Series B 1995, 57:289-300.
26. Armitage P. Tests for linear trends in proportions and frequencies. Biometrics 1955, 11:375-386.
27. Tucker SL. Tests for the fit of the linear-quadratic model to radiation isoeffect data. Int J Radiat Oncol Biol Phys 1984, 10:1933-1939.
28. Vacca A, Scavelli C, Serini G, Di Pietro G, Cirulli T, Merchionne F, Ribatti D, Bussolino F, Guidolin D, Piaggio G, Bacigalupo A, Dammacco F. Loss of inhibitory semaphorin 3A (SEMA3A) autocrine loops in bone marrow endothelial cells of patients with multiple myeloma. Blood 2006, 108:1661-1667. 10.1182/blood-2006-04-014563, 16684957.
29. Narazaki M, Segarra M, Tosato G. Sulfated polysaccharides identified as inducers of neuropilin-1 internalization and functional inhibition of VEGF165 and semaphorin3A. Blood 2008, 111:4126-4136. 10.1182/blood-2007-09-112474, 2288723, 18272814.
30. Guttmann-Raviv N, Shraga-Heled N, Varshavsky A, Guimaraes-Sternberg C, Kessler O, Neufeld G. Semaphorin-3A and semaphorin-3F work together to repel endothelial cells and to inhibit their survival by induction of apoptosis. J Biol Chem 2007, 282:26294-26305. 10.1074/jbc.M609711200, 17569671.
31. Serini G, Valdembri D, Zanivan S, Morterra G, Burkhardt C, Caccavari F, Zammataro L, Primo L, Tamagnone L, Logan M, Tessier-Lavigne M, Taniguchi M, Püschel AW, Bussolino F. Class 3 semaphorins control vascular morphogenesis by inhibiting integrin function. Nature 2003, 424:391-397. 10.1038/nature01784, 12879061.
32. Barresi V, Vitarelli E, Cerasoli S. Semaphorin3A immunohistochemical expression in human meningiomas: correlation with the microvessel density. Virchows Arch 2009, 454:563-571. 10.1007/s00428-009-0757-3, 19296128.
33. Moretti S, Procopio A, Lazzarini R, Rippo MR, Testa R, Marra M, Tamagnone L, Catalano A. Semaphorin3A signaling controls Fas (CD95)-mediated apoptosis by promoting Fas translocation into lipid rafts. Blood 2008, 111:2290-2299. 10.1182/blood-2007-06-096529, 18056484.
34. Schmidt EF, Strittmatter SM. The CRMP family of proteins and their role in Sema3A signaling. Adv Exp Med Biol 2007, 600:1-11. full_text, 2853248, 17607942.
35. Tannemaat MR, Korecka J, Ehlert EM, Mason MR, van Duinen SG, Boer GJ, Malessy MJ, Verhaagen J. Human neuroma contains increased levels of semaphorin 3A, which surrounds nerve fibers and reduces neurite extension in vitro. J Neurosci 2007, 27:14260-14264. 10.1523/JNEUROSCI.4571-07.2007, 18160633.
36. Herman JG, Meadows GG. Increased class 3 semaphorin expression modulates the invasive and adhesive properties of prostate cancer cells. Int J Oncol 2007, 30:1231-1238.
37. Kurschat P, Bielenberg D, Rossignol-Tallandier M, Stahl A, Klagsbrun M. Neuron restrictive silencer factor NRSF/REST is a transcriptional repressor of neuropilin-1 and diminishes the ability of semaphorin 3A to inhibit keratinocyte migration. J Biol Chem 2006, 281:2721-2729. 10.1074/jbc.M507860200, 16330548.
38. Lepelletier Y, Smaniotto S, Hadj-Slimane R, Villa-Verde DM, Nogueira AC, Dardenne M, Hermine O, Savino W. Control of human thymocyte migration by neuropilin-1/semaphorin-3A-mediated interactions. Proc Natl Acad Sci USA 2007, 104:5545-5550. 10.1073/pnas.0700705104, 1838472, 17369353.
39. Bachelder RE, Lipscomb EA, Lin X, Wendt MA, Chadborn NH, Eickholt BJ, Mercurio AM. Competing autocrine pathways involving alternative neuropilin-1 ligands regulate chemotaxis of carcinoma cells. Cancer Res 2003, 63:5230-5233.
40. Ko JA, Morishige N, Yanai R, Nishida T. Up-regulation of semaphorin 3A in human corneal fibroblasts by epidermal growth factor released from cocultured human corneal epithelial cells. Biochem Biophys Res Commun 2008, 377:104-108. 10.1016/j.bbrc.2008.09.085, 18831963.
41. Kashiwagi H, Shiraga M, Kato H, Kamae T, Yamamoto N, Tadokoro S, Kurata Y, Tomiyama Y, Kanakura Y. Negative regulation of platelet function by a secreted cell repulsive protein, semaphorin 3A. Blood 2005, 106:913-921. 10.1182/blood-2004-10-4092, 15831706.
42. Lepelletier Y, Moura IC, Hadj-Slimane R, Renand A, Fiorentino S, Baude C, Shirvan A, Barzilai A, Hermine O. Immunosuppressive role of semaphorin-3A on T cell proliferation is mediated by inhibition of actin cytoskeleton reorganization. Eur J Immunol 2006, 36:1782-1793. 10.1002/eji.200535601, 16791896.
43. Marzioni D, Tamagnone L, Capparuccia L, Marchini C, Amici A, Todros T, Bischof P, Neidhart S, Grenningloh G, Castellucci M. Restricted innervation of uterus and placenta during pregnancy: evidence for a role of the repelling signal semaphorin 3A. Dev Dyn 2004, 231:839-848. 10.1002/dvdy.20178, 15517571.
44. Eastwood SL, Law AJ, Everall IP, Harrison PJ. The axonal chemorepellant semaphorin 3A is increased in the cerebellum in schizophrenia and may contribute to its synaptic pathology. Mol Psychiatry 2003, 8:148-155. 10.1038/sj.mp.4001233, 12610647.
45. Potiron VA, Roche J, Drabkin HA. Semaphorins and their receptors in lung cancer. Cancer Lett 2009, 273:1-14. 10.1016/j.canlet.2008.05.032, 2630718, 18625544.
46. Catalano A, Caprari P, Rodilossi S, Betta P, Castellucci M, Casazza A, Tamagnone L, Procopio A. Cross-talk between vascular endothelial growth factor and semaphorin-3A pathway in the regulation of normal and malignant mesothelial cell proliferation. FASEB J 2004, 18:358-363.
47. Rieger J, Wick W, Weller M. Human malignant glioma cells express semaphorins and their receptors, neuropilins and plexins. Glia 2003, 42:379-389. 10.1002/glia.10210, 12730958.
48. Müller MW, Giese NA, Swiercz JM, Ceyhan GO, Esposito I, Hinz U, Büchler P, Giese T, Büchler MW, Offermanns S, Friess H. Association of axon guidance factor semaphorin 3A with poor outcome in pancreatic cancer. Int J Cancer 2007, 121:2421-2433. 10.1002/ijc.22949, 17631638.
49. Kigel B, Varshavsky A, Kessler O, Neufeld G. Successful inhibition of tumor development by specific class-3 semaphorins is associated with expression of appropriate semaphorin receptors by tumor cells. PLoS One 2008, 3:e3287. 10.1371/journal.pone.0003287, 2538586, 18818766.
50. Brieger J, Kattwinkel J, Berres M, Gosepath J, Mann WJ. Impact of vascular endothelial growth factor release on radiation resistance. Oncol Rep 2007, 18:1597-1601.
51. Horowitz RA, Agard DA, Sedat JW, Woodcock C. The three-dimensional architecture of chromatin in situ: electron tomography reveals fibers composed of a continuously variable zig-zag nucleosomal ribbon. J Cell Biol 1994, 125:1-10. 10.1083/jcb.125.1.1, 2120010, 8138564.
52. Spencer CC, Su Z, Donnelly P, Marchini J. Designing genome-wide association studies: sample size, power, imputation, and the choice of genotyping chip. PLoS Genet 2009, 5:e1000477. 10.1371/journal.pgen.1000477, 2688469, 19492015.
53. NCI-NHGRI working group on replication in association studies Replicating genotype-phenotype associations. Nature 2007, 447:655-660. 10.1038/447655a, 17554299, NCI-NHGRI working group on replication in association studies.
54. Kikuchi K, Kishino A, Konishi O, Kumagai K, Hosotani N, Saji I, Nakayama C, Kimura T. In vitro and in vivo characterization of a novel semaphorin 3A inhibitor, SM-216289 or xanthofulvin. J Biol Chem 2003, 278:42985-42991. 10.1074/jbc.M302395200, 12933805.
55. Kaneko S, Iwanami A, Nakamura M, Kishino A, Kikuchi K, Shibata S, Okano HJ, Ikegami T, Moriya A, Konishi O, Nakayama C, Kumagai K, Kimura T, Sato Y, Goshima Y, Taniguchi M, Ito M, He Z, Toyama Y, Okano H. A selective Sema3A inhibitor enhances regenerative responses and functional recovery of the injured spinal cord. Nat Med 2006, 12:1380-1389. 10.1038/nm1505, 17099709.
56. Diskin SJ, Hou C, Glessner JT, Attiyeh EF, Laudenslager M, Bosse K, Cole K, Mossé YP, Wood A, Lynch JE, Pecor K, Diamond M, Winter C, Wang K, Kim C, Geiger EA, McGrady PW, Blakemore AI, London WB, Shaikh TH, Bradfield J, Grant SF, Li H, Devoto M, Rappaport ER, Hakonarson H, Maris JM. Copy number variation at 1q21.1 associated with neuroblastoma. Nature 2009, 459:987-991. 10.1038/nature08035, 2755253, 19536264.
57. Johannes F, Porcher E, Teixeira FK, Saliba-Colombani V, Simon M, Agier N, Bulski A, Albuisson J, Heredia F, Audigier P, Bouchez D, Dillmann C, Guerche P, Hospital F, Colot V. Assessing the impact of transgenerational epigenetic variation on complex traits. PLoS Genet 2009, 5:e1000530. 10.1371/journal.pgen.1000530, 2696037, 19557164.
58. Ansorge WJ. Next-generation DNA sequencing techniques. Nat Biotechnol 2009, 25:195-203.